← Back to Search

Decision Aid Web Tool for Kidney Cancer

N/A
Recruiting
Led By Stella Kang, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter
Be older than 18 years old
Must not have
Stage IV cancer of any type
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-counsel, 1 day visit
Awards & highlights

Summary

This trial is to study how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Who is the study for?
This trial is for men and women over 18 who are seeing a urologist at NYU for kidney tumors no larger than 4 cm. It's open to patients before and after surgery but not to those with stage IV cancer or anyone unable to consent.Check my eligibility
What is being tested?
The study is testing a new web tool called Decision Aid (DA) against the usual information pamphlets given by hospitals. The DA aims to help kidney tumor patients understand their treatment options better.See study design
What are the potential side effects?
Since this trial involves informational tools rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety when making treatment decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with a kidney tumor no larger than 4 cm.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer is at stage IV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-counsel, 1 day visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-counsel, 1 day visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decision Satisfaction Score
Knowledge Score
Shared Decision Making

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Decision Aid (DA) Web ToolExperimental Treatment1 Intervention
Group II: Institutional PamphletActive Control1 Intervention

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,379 Previous Clinical Trials
848,078 Total Patients Enrolled
Stella Kang, MDPrincipal InvestigatorNYU Langone Health

Media Library

Decision Aid (DA) Web Tool Clinical Trial Eligibility Overview. Trial Name: NCT05387863 — N/A
Kidney Tumors Research Study Groups: Decision Aid (DA) Web Tool, Institutional Pamphlet
Kidney Tumors Clinical Trial 2023: Decision Aid (DA) Web Tool Highlights & Side Effects. Trial Name: NCT05387863 — N/A
Decision Aid (DA) Web Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT05387863 — N/A
~14 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top